Comparing the World Health Organization-versus China-recommended protocol for first-trimester medical abortion: a retrospective analysis
- PMID: 22505831
- PMCID: PMC3325005
- DOI: 10.2147/IJWH.S30354
Comparing the World Health Organization-versus China-recommended protocol for first-trimester medical abortion: a retrospective analysis
Abstract
Objective: To compare the effectiveness, in terms of complete abortion, of the World Health Organization (WHO)- and the China-recommended protocol for first-trimester medical abortion.
Methods: A retrospective analysis of clinical data from women presenting for first trimester medical abortion between January 2009 and August 2010 at reproductive health clinics in Qingdao, Xi'an, Nanjing, Nanning, and Zhengzhou was conducted. One clinic in Qingdao administered the WHO-recommended protocol (200 mg mifepristone orally followed by 0.8 mg misoprostol buccally 36-48 hours later). Four clinics in the other locations provided the China-recommended procedure (Day 1: 50 mg of mifepristone in the morning, 25 mg in the afternoon; Day 2: 50 mg of mifepristone in the morning, 25 mg in the afternoon; Day 3: 0.6 mg oral misoprostol). Data on reproductive and demographic characteristics were extracted from clinic records, and complete termination was determined on day 14 (post-mifepristone administration).
Results: A total of 337 women underwent early medical abortion (167 WHO- and 170 China-recommended procedures). Complete abortion was significantly higher among women who had the WHO protocol than those who received the China protocol (91.0% vs 77.7%, respectively; P < 0.001). Women using the China-recommended protocol were three times more likely to require an additional dose of misoprostol than women using the WHO protocol (21.8% vs 7.8%, respectively; P < 0.001), and had significantly more bleeding on the day of misoprostol administration (12.5 mL vs 18.5 mL; P < 0.001).
Conclusion: This clinical audit provides preliminary evidence suggesting the WHO-recommended protocol may be more effective than the China-recommended protocol for early medical abortion. A larger scale study is necessary to compare the methods' effectiveness and acceptability.
Keywords: China; first-trimester termination; medical abortion; mifepristone; misoprostol.
References
-
- Nicolaou KC, Sorensen EJ. Classics in Total Synthesis: Targets, Strategies, Methods. Weinheim, Germany: Wiley-VCH; 1996.
-
- Kulier R, Gulmezoglu AM, Hofmeyr GJ, Cheng LN, Campana A. Medical methods for first trimester abortion. Cochrane Database Syst Rev. 2004;2:CD002855. - PubMed
-
- Creinin MD, Fox MC, Teal S, Chen A, Schaff EA, Meyn LA MOD Trial Group. A randomized comparison of misoprostol 6 to 8 hours versus 24 hours after mifepristone for abortion. Obstet Gynecol. 2004;103(5 Pt 1):851–859. - PubMed
-
- Creinin MD, Schreiber CA, Bednarek P, Lintu H, Wagner MS, Meyn LA Medical Abortion at the Same Time (MAST) Study Trial Group. Mifepristone and misoprostol administered simultaneously versus 24 hours apart for abortion: a randomized controlled trial. Obstet Gynecol. 2007;109(4):885–894. - PubMed
-
- Shannon C, Wiebe E, Jacot F, et al. Regimens of misoprostol with mifepristone for early medical abortion: a randomised trial. BJOG. 2006;113(6):621–628. - PubMed
LinkOut - more resources
Full Text Sources
